Ledipasvir (GS-5885)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ledipasvir (GS-5885), covering 2014-02-03 to 2014-02-03. Get the full timeline:
Most recent: Clinical Trial Update: GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus [Phase 2]